Investing.com - Quince Therapeutics Inc. (NASDAQ:QNCX), a clinical-stage biotech with a market capitalization of $87.55 million, maintained its Market Outperform rating and $8.00 price target from JMP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results